Drug profile · INN
epoetin zeta
RETACRIT
epoetin zeta (RETACRIT) is a erythropoietin receptor agonist.
EMA: approved Blood and blood forming organs (B03) B03XA01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — epoetin zeta
- Class
- Blood and blood forming organs (B03)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
epoetin zeta (RETACRIT) is a erythropoietin receptor agonist.
Key facts
INN epoetin zeta
Brand RETACRIT
Mechanism Erythropoietin receptor agonist
Target Erythropoietin receptor
Therapeutic class Blood and blood forming organs (B03)
ATC code B03XA01
Mechanism of action
Erythropoietin receptor agonist
Primary target: Erythropoietin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is epoetin zeta?
epoetin zeta (RETACRIT) is a erythropoietin receptor agonist.
What is the brand name for epoetin zeta?
RETACRIT is a marketed brand name for epoetin zeta. Check FDA Drugs@FDA for the current US label holder and prescribing information.